Advisor Group Holdings, Inc. Biomerica Inc Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.42 - $0.86 $11,592 - $23,736	-27,600 Reduced 95.83%	1,200 $0
Q1 2024 May 10, 2024	BUY	$0.82 - $1.29 $6,396 - $10,062	7,800 Added 37.14%	28,800 $23,000
Q4 2023 Feb 12, 2024	BUY	$0.71 - $1.65 $12,694 - $29,500	17,879 Added 572.86%	21,000 $26,000
Q3 2023 Nov 13, 2023	BUY	$0.82 - $1.65 $1,288 - $2,592	1,571 Added 101.35%	3,121 $2,000
Q4 2022 Feb 10, 2023	BUY	$2.98 - $4.17 $149 - $208	50 Added 3.33%	1,550 $5,000
Q3 2022 Nov 14, 2022	BUY	$2.61 - $3.98 $3,784 - $5,771	1,450 Added 2900.0%	1,500 $6,000
Q1 2021 May 13, 2021	SELL	$5.06 - $8.0 $177 - $280	-35 Reduced 41.18%	50 $0
Q2 2020 Aug 14, 2020	SELL	$5.17 - $8.95 $2,662 - $4,609	-515 Reduced 85.83%	85 $0
Q1 2020 May 18, 2020	BUY	$2.37 - $16.0 $1,422 - $9,600	600 New	600 $4,000

1.79M

53.7K

Ticker BMRA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,427,700
Market Cap $3.76M
Description
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.